Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth

Completed · Not applicable

Conditions studied: Non-alcoholic Fatty Liver Disease

In brief

The purpose of this study is to see if the HepaFat-Scan (a special sequence of images done in a MRI) can accurately detect the amount of fat in the liver.

Key facts

Study ID

NCT02461212

Run by

Emory University

People needed

50

Starts

2015-07-01

Expected to finish

2017-03-17

Last updated by the study team

2017-04-10

Who can join

Age: 7 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Boys and girls age 7-18 years
• Scheduled for a clinically indicated liver biopsy
• Able to undergo MRI without sedation
• Written informed consent from parent or legal guardian
• Written informed assent from the child when indicated by age

You may not qualify if…

• Renal disease with a creatinine > 2 or requiring dialysis
• Metal, braces or other implanted devices not compatible with MRI
• Not willing to try to hold still for an un-sedated MRI
• Pregnancy
• Failure to give consent or assent

Where it is running

• Children's Healthcare of Atlanta at Egleston — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.